Anika Therapeutics | ANIK - Passivo Circulante





Passivo Circulante Alterar Data
Abbott USD 18.38B 1.88B 2026-03
Agenus USD 231.82M 17.42M 2026-06
Agios Pharmaceuticals USD 70.22M 11.37M 2026-06
Anika Therapeutics USD 22.15M 1.18M 2026-06
Arrowhead Research USD 283.35M 11.87M 2026-06
Enanta Pharmaceuticals USD 44.73M 3.83M 2025-12
Halozyme Therapeutics USD 344.44M 18.77M 2026-06
Heron Therapeutics USD 92.14M 1.63M 2026-06
Insmed USD 438.74M 77.74M 2026-06
Integra LifeSciences USD 330.88M 15.96M 2026-06
Intrexon USD 23.02M 38K 2024-06
J&J USD 54.9B 2.82B 2026-06
Karyopharm Therapeutics USD 117.3M 25.24M 2026-03
Ligand Pharmaceuticals USD 46.74M 6.07M 2026-06
MacroGenics USD 108.82M 12.88M 2026-06
Merit Medical Systems USD 264.93M 48.06M 2026-06
Rigel Pharmaceuticals USD 94.4M 7.76M 2025-09
Sangamo BioSciences USD 47.66M 1.9M 2025-06
Sanofi EUR 31.93B 1.92B 2026-06
Smith & Nephew USD 2.05B 510M 2026-06
Stryker USD 6.68B 369M 2026-06
Veracyte USD 62.74M 6.62M 2026-06
Xencor USD 81.86M 8.41M 2026-06
Zimmer Biomet Holdings USD 3.01B 149.2M 2026-06